SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-19-065668
Filing Date
2019-03-06
Accepted
2019-03-06 16:48:32
Documents
2
Group Members
11188291 CANADA INC.

Document Format Files

Seq Description Document Type Size
1 SC 13D d680646dsc13d.htm SC 13D 110743
2 EX-99.1.01 d680646dex99101.htm EX-99.1.01 3902
  Complete submission text file 0001193125-19-065668.txt   116192
Mailing Address 42, RUE DU DOCTEUR BLANCHE PARIS I0 75016
Business Address 42, RUE DU DOCTEUR BLANCHE PARIS I0 75016 011 33144961010
Ipsen, S.A. (Filed by) CIK: 0001370483 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 1000 DE LA GAUCHETIERE STREET WEST SUITE 1200 MONTREAL A8 H3B 4W5
Business Address 1000 DE LA GAUCHETIERE STREET WEST SUITE 1200 MONTREAL A8 H3B 4W5 (514) 940-3600
Clementia Pharmaceuticals Inc. (Subject) CIK: 0001647320 (see all company filings)

IRS No.: 981128564 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90071 | Film No.: 19663115
SIC: 2834 Pharmaceutical Preparations